Standard Biotools | FLDM - Equity Capital And Reserves


Standard Biotools reported $561.12M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 2.44B 67M Jun/2026
Danaher USD 52.58B 368M Jun/2026
Illumina USD 2.84B 162M Jun/2026
Myriad Genetics USD 303.9M 33.5M Jun/2026
Nikon Corporation JPY 593.36B 6.58B Jun/2026
Pacific Biosciences Of California USD -33.21M 35.58M Jun/2026
Revvity USD 7.18B 67.62M Mar/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sony JPY 8.37T 250.25B Jun/2026
Standard Biotools USD 561.12M 136.83M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Waters USD 15.29B 12.73B Mar/2026